M, F., MI, T., C, H., MJ, M., PC, M., LA, K., . . . M, K. (2026). Rates and Predictors of Persistent LUTS Medication Use After Laser Enucleation of the Prostate. Lower urinary tract symptoms, 18(3), e70062. https://doi.org/10.1111/luts.70062
Chicago Style (17th ed.) CitationM, Filzmayer, Traumann MI, Humke C, Müller MJ, Mandel PC, Kluth LA, Becker A, Chun FK, and Kosiba M. "Rates and Predictors of Persistent LUTS Medication Use After Laser Enucleation of the Prostate." Lower Urinary Tract Symptoms 18, no. 3 (2026): e70062. https://doi.org/10.1111/luts.70062.
MLA (9th ed.) CitationM, Filzmayer, et al. "Rates and Predictors of Persistent LUTS Medication Use After Laser Enucleation of the Prostate." Lower Urinary Tract Symptoms, vol. 18, no. 3, 2026, p. e70062, https://doi.org/10.1111/luts.70062.